ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 274,48
-0,27%
Dow Jones
42 840,26
1,18%
DAX
19 884,75
-0,57%
Brent Oil
72,72
0,00%
Bitcoin
97 136,86
-0,64%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Royaume-Uni
  5. LSE

  6. Active Biotech Ab (0GQU) Cours

Active Biotech Ab

Active Biotech Ab (0GQU)

LSE
2,85
0,00
(0,00%)
Fermé 21 Décembre 5:30PM
Retardé de 15 minutes

Votre Hub pour des idées et discussions en direct en temps réel

Premium

Statistiques et détails clés

Dernier
2,85
Prix Achat
0,00
Prix Vente
0,00
Volume échangé
0,00
0,00 Fourchette du Jour 0,00
2,85 Plage de 52 semaines 2,85
Cap du marché
1,031B
Clôture Veille
2,85
Ouverture
-
Dernière Transaction
(O)
Dernière heure de transaction
Volume financier
-
VWAP
-
Volume moyen (3 m)
704
Actions en circulation
361 739 000
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-22,51
Bénéfice par action (BPA)
-0,13
Chiffre d'affairess
-
Bénéfice net
-45,8M

À propos de Active Biotech Ab

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Diversified
Site Web
www.activebiotech.com
Siège social
Lund, Swe
Fondé
1994
Active Biotech Ab est coté dans le secteur Pharmaceutical Preparations de la London Stock Exchange avec le ticker 0GQU. Le dernier cours de clôture d'Active Biotech Ab était de SEK2,85. Au cours de la dernière année, les actions de Active Biotech Ab ont été négociées dans une fourchette de prix de SEK 2,85 à SEK 2,85.

Active Biotech Ab compte actuellement 361 739 000 actions en circulation. La capitalisation boursière d'Active Biotech Ab est de SEK1,03 milliard. Active Biotech Ab a un ratio cours/bénéfice (ratio PE) de -22.51.

0GQU Dernières nouvelles

Plus de nouvelles

Successful completion of the first stage of the phase IIa clinical trial of naptumomab in combination with docetaxel and the study is now enrolling into the second stage

Successful completion of the first stage of the phase IIa clinical trial of naptumomab in combination with docetaxel and the study is now enrolling into the second stage Lund, June 1, 2022...

01 Juin 2022
GlobeNewswire Inc.

Annual General Meeting of Active Biotech AB

Annual General Meeting of Active Biotech AB The Annual General Meeting of Active Biotech was held on May 19, 2022. Due to the situation resulting from the Corona virus, the Meeting was...

19 Mai 2022
GlobeNewswire Inc.

FDA grants Orphan Drug Designation for tasquinimod in myelofibrosis

FDA grants Orphan Drug Designation for tasquinimod in myelofibrosis   Lund May 18, 2022 - Active Biotech AB (Nasdaq Stockholm: ACTI) today announced that the U.S. Food and Drug Administration...

18 Mai 2022
GlobeNewswire Inc.

Annual Report 2021 Active Biotech AB (publ)

Annual Report 2021 Active Biotech AB (publ) Active Biotech's Annual Report 2021 is now available for download at www.activebiotech.com. The Annual Report will only be digitally distributed...

28 Avril 2022
GlobeNewswire Inc.

Active Biotech strengthens the patent protection for laquinimod in eye disorders

Active Biotech strengthens the patent protection for laquinimod in eye disorders Lund, April 26, 2022, Active Biotech (NASDAQ STOCKHOLM: ACTI) today announced that the European Patent Office...

26 Avril 2022
GlobeNewswire Inc.

Active Biotech Interim Report Q1 2022

Active Biotech Interim Report Q1 2022 FIRST QUARTER IN BRIEF Dr. Erik Vahtola appointed Chief Medical Officer (Jan 01)First patient dosed in the combination part of the phase Ib/IIa study of...

21 Avril 2022
GlobeNewswire Inc.

Active Biotech: NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS

Active Biotech: NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS The shareholders of Active Biotech AB (publ) are invited to the Annual General Meeting of shareholders to be held on Thursday...

20 Avril 2022
GlobeNewswire Inc.

Number of shares and votes in Active Biotech

Number of shares and votes in Active Biotech The number of shares and votes in Active Biotech has changed as a result of allotment of performance shares under the company’s incentive program...

31 Mars 2022
GlobeNewswire Inc.

Correction: Active Biotech Year End Report 2021

Correction: Active Biotech Year End Report 2021 The correction refers to the administrative costs for the period January – December 2021 that due to oversight have been stated too low. The...

25 Mars 2022
GlobeNewswire Inc.

Active Biotech: Year End Report 2021

Active Biotech: Year End Report 2021 FOURTH QUARTER IN BRIEF In 2021, we made substantial progress in our projects to address unmet medical need in hematological cancers and inflammatory eye...

09 Février 2022
GlobeNewswire Inc.
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1002.852.852.8512.85DE
4002.852.852.8519052.85DE
12002.852.852.857042.85DE
26002.852.852.853542.85DE
52002.852.852.851972.85DE
156002.852.852.854392.85DE
260002.852.852.856422.85DE

0GQU - Frequently Asked Questions (FAQ)

What is the current Active Biotech Ab share price?
The current share price of Active Biotech Ab is SEK 2,85
How many Active Biotech Ab shares are in issue?
Active Biotech Ab has 361 739 000 shares in issue
What is the market cap of Active Biotech Ab?
The market capitalisation of Active Biotech Ab is SEK 1,03B
What is the 1 year trading range for Active Biotech Ab share price?
Active Biotech Ab has traded in the range of SEK 2,85 to SEK 2,85 during the past year
What is the PE ratio of Active Biotech Ab?
The price to earnings ratio of Active Biotech Ab is -22,51
What is the reporting currency for Active Biotech Ab?
Active Biotech Ab reports financial results in SEK
What is the latest annual profit for Active Biotech Ab?
The latest annual profit of Active Biotech Ab is SEK -45,8M
What is the registered address of Active Biotech Ab?
The registered address for Active Biotech Ab is SCHEELEVAGEN 22, LUND, SE-223 63
What is the Active Biotech Ab website address?
The website address for Active Biotech Ab is www.activebiotech.com
Which industry sector does Active Biotech Ab operate in?
Active Biotech Ab operates in the PHARMACEUTICAL DIVERSIFIED sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
TIRTiger Royalties And Investments Plc
0,15p
(50,00%)
3,41M
BAYBay Capital Plc
5,50p
(19,57%)
209,68k
MASTMast Energy Developments Plc
0,19p
(18,75%)
20,09M
MHNMenhaden Resource Efficiency Plc
148,50p
(18,33%)
1M
ZENZenith Energy Ltd.
2,50p
(16,28%)
3,93M
TRYBTribe Technology Plc
0,115p
(-79,09%)
24,27M
NMTNeometals Ltd
2,75p
(-35,29%)
49,4k
SNGSynairgen Plc
2,46p
(-34,31%)
4,31M
TM1Technology Minerals Plc
0,185p
(-26,00%)
174,03M
AYMAnglesey Mining Plc
0,70p
(-17,65%)
2,99M
NTVONativo Resources Plc
0,002p
(5,26%)
971,94M
TRPTower Resources Plc
0,035p
(9,38%)
620,03M
LLOYLloyds Banking Group Plc
54,16p
(-0,26%)
341,48M
ORCPOracle Power Plc
0,0255p
(-1,92%)
192,93M
TM1Technology Minerals Plc
0,185p
(-26,00%)
174,03M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

LSE
0GQU
Active Biotech Ab
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés